Ardelyx reported $109.57M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Abbott USD 18.38B 1.88B Mar/2026
Amgen USD 25.5B 547M Jun/2026
Ardelyx USD 109.57M 20.96M Mar/2026
aTyr Pharma USD 11.4M 303K Jun/2026
Corcept Therapeutics USD 153.8M 4.62M Jun/2026
Curis USD 14.97M 898K Mar/2026
Sanofi EUR 30.01B 1.66B Mar/2026
TG Therapeutics USD 268.49M 81.38M Jun/2026
United Therapeutics USD 607.8M 8.7M Jun/2026